Felix Pharmaceuticals seeks $200-250mn for controlling stake in pet drug subsidiary, Felix Generics, amid booming market
The Ireland-headquartered Felix Pharmaceuticals, which is eyeing a valuation of around $200-250 million for the controlling ...